Article Details
Retrieved on: 2020-12-06 23:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
To be eligible for enrollment, patients had to have CD20-positive relapsed/refractory B-cell <b>NHL</b>, had prior treatment with an anti-CD20 antibody, ...
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here